{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:27:22Z","timestamp":1790800042754,"version":"4.1.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Ministry for Health & Welfare Affairs of Korea","award":["HI12C-0022-030014"],"award-info":[{"award-number":["HI12C-0022-030014"]}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2015R1A2A1A01004677"],"award-info":[{"award-number":["NRF-2015R1A2A1A01004677"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Anal Bioanal Chem"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1007\/s00216-016-9318-1","type":"journal-article","created":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T12:32:03Z","timestamp":1455280323000},"page":"2265-2274","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Variations in plasma and urinary lipids in response to enzyme replacement therapy for Fabry disease patients by nanoflow UPLC-ESI-MS\/MS"],"prefix":"10.1007","volume":"408","author":[{"given":"Seul Kee","family":"Byeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Sung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myeong Hee","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,2,12]]},"reference":[{"key":"9318_CR1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00005792-200203000-00003","volume":"81","author":"MH Branton","year":"2002","unstructured":"Branton MH, Schiffmann R, Sabnis SG, Murray GJ, Quirk JM, Altarescu G, et al. Natural history of Fabry renal disease: infleucne of \u03b1-galactosidase A activity and genetic mutations on clinical course. Medicine. 2002;81:122\u201338.","journal-title":"Medicine"},{"key":"9318_CR2","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.281.3.249","volume":"281","author":"PJ Meikle","year":"1999","unstructured":"Meikle PJ, Hopwood JJ, Clague AE, Carrey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249\u201351.","journal-title":"JAMA"},{"key":"9318_CR3","first-page":"182","volume":"18","author":"KC Tse","year":"2003","unstructured":"Tse KC, Chan KW, Tin VP, Yip PS, Tang S, Li FK, et al. Clinical features and genetic analysis of a Chinese kindred with Fabry\u2019s disease. Nephrol Dial Transplant. 2003;18:182\u20136.","journal-title":"Nephrol Dial Transplant"},{"key":"9318_CR4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1365-2796.2004.01300.x","volume":"255","author":"AC Hauser","year":"2004","unstructured":"Hauser AC, Lorenz M, Sunder-Plassmann G. The expanding clinical spectrum of Anderson\u2013Fabry disease: a challenge to diagnosis in the novel era of enzyme replacement therapy. J Intern Med. 2004;255:629\u201336.","journal-title":"J Intern Med"},{"key":"9318_CR5","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1093\/qjmed\/hcq117","volume":"103","author":"A Mehta","year":"2010","unstructured":"Mehta A, Beck M, Eyskens F, Feliciani C, Kantola I, Ramaswami U, et al. Fabry disease: a review of current management strategies. QJM. 2010;103:641\u201359.","journal-title":"QJM"},{"key":"9318_CR6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11739-012-0821-x","volume":"7","author":"F Carubbi","year":"2012","unstructured":"Carubbi F, Bonilauri L. Fabry disease: raising awareness of the disease among physicians. Intern Emerg Med. 2012;7:227\u201331.","journal-title":"Intern Emerg Med"},{"key":"9318_CR7","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/01.CIR.0000091253.71282.04","volume":"108","author":"F Weidemann","year":"2003","unstructured":"Weidemann F, Breunig F, Beer M, Sandstede J, Turschner O, Voelker W, et al. Improvement of cardiac function during enzyme replacement therapy in patients with Fabry disease. Circulation. 2003;108:1299\u2013301.","journal-title":"Circulation"},{"key":"9318_CR8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0022-2275(20)33352-6","volume":"40","author":"JFHM Brouwers","year":"1999","unstructured":"Brouwers JFHM, Vernooji EAAM, Tielens AGM, van Golde LMG. Rapid separation and identification of phosphatidylethanolamine molecular species. J Lipid Res. 1999;40:164\u20139.","journal-title":"J Lipid Res"},{"key":"9318_CR9","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1139\/o03-092","volume":"82","author":"MM Wright","year":"2004","unstructured":"Wright MM, Howe AG, Zaremberg V. Cell membranes and apoptosis: role of cardiolipin, phosphatidylcholine, and anticancer lipid analogues. Biochem Cell Biol. 2004;82:18\u201326.","journal-title":"Biochem Cell Biol"},{"key":"9318_CR10","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0165-0270(03)00168-7","volume":"128","author":"G Isaac","year":"2003","unstructured":"Isaac G, Bylund D, M\u00e5nsson JE, Markides KE, Bergquist J. Analysis of phosphatidylcholine and sphingomyelin molecular species from brain extracts using capillary liquid chromatography electrospray ionization mass spectrometry. J Neurosci Methods. 2003;128:111\u20139.","journal-title":"J Neurosci Methods"},{"key":"9318_CR11","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/1096-9888(200008)35:8<953::AID-JMS23>3.0.CO;2-4","volume":"35","author":"R Taguchi","year":"2000","unstructured":"Taguchi R, Hayakawa J, Takeuchi Y, Ishida M. Two-dimensional analysis of phospholipids by capillary liquid chromatography\/electrospray ionization mass spectrometry. J Mass Spectrom. 2000;35:953\u201366.","journal-title":"J Mass Spectrom"},{"key":"9318_CR12","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.chroma.2013.08.069","volume":"1310","author":"DY Bang","year":"2013","unstructured":"Bang DY, Moon MH. On-line two-dimensional capillary strong anion exchange\/reversed phase liquid chromatography-tandem mass spectrometry for comprehensive lipid analysis. J Chromatogr A. 2013;1310:82\u201390.","journal-title":"J Chromatogr A"},{"key":"9318_CR13","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.5012\/bkcs.2014.35.4.1133","volume":"35","author":"S Lim","year":"2014","unstructured":"Lim S, Bang DY, Rha KH, Moon MH. Rapid screening of phospholipid biomarker candidates from prostate cancer urine samples by multiple reaction monitoring of UPLC-ESI-MS\/MS and statistical approaches. Bull Korean Chem Soc. 2014;35:1133\u20138.","journal-title":"Bull Korean Chem Soc"},{"key":"9318_CR14","doi-asserted-by":"crossref","first-page":"5343","DOI":"10.1021\/ac300772w","volume":"84","author":"JY Kim","year":"2012","unstructured":"Kim JY, Kim S-K, Kang D, Moon MH. Dual lectin-based size sorting strategy to enrich targeted N-glycopeptides by asymmetrical flow field-flow fractionation: profiling lung cancer biomarkers. Anal Chem. 2012;84:5343\u201350.","journal-title":"Anal Chem"},{"key":"9318_CR15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.chroma.2012.11.012","volume":"1270","author":"SK Byeon","year":"2012","unstructured":"Byeon SK, Lee JY, Lim S, Choi D, Moon MH. Discovery of candidate phospholipid biomarkers in human lipoproteins with coronary artery disease by flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2012;1270:246\u201353.","journal-title":"J Chromatogr A"},{"key":"9318_CR16","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00216-010-4290-7","volume":"399","author":"HK Min","year":"2011","unstructured":"Min HK, Lim S, Chung BC, Moon MH. Shotgun lipidomics for potential biomarkers of urinary phospholipids in prostate cancer. Anal Bioanal Chem. 2011;399:823\u201330.","journal-title":"Anal Bioanal Chem"},{"key":"9318_CR17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5478\/MSL.2014.5.1.1","volume":"5","author":"MH Moon","year":"2014","unstructured":"Moon MH. Phospholipid analysis by nanoflow liquid chromatography-tandem mass spectrometry. Mass Spectrometry Letters. 2014;5:1\u201311.","journal-title":"Mass Spectrometry Letters"},{"key":"9318_CR18","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1021\/ac503973p","volume":"87","author":"JY Lee","year":"2015","unstructured":"Lee JY, Byeon SK, Moon MH. Profiling of oxidized phospholipids in lipoproteins from patients with coronary artery disease by hollow fiber flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry. Anal Chem. 2015;87:1266\u201373.","journal-title":"Anal Chem"},{"key":"9318_CR19","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1081\/JLC-200053046","volume":"28","author":"ME Swartz","year":"2005","unstructured":"Swartz ME. \u201cUPLC: an introduction and review\u201d. J Liq Chromatogr. 2005;28:1253\u201363.","journal-title":"J Liq Chromatogr"},{"key":"9318_CR20","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.chroma.2006.05.024","volume":"1124","author":"M Petrovic","year":"2006","unstructured":"Petrovic M, Gros M, Barcelo D. Multi-residue analysis of pharmaceuticals in wastewater by ultra-performance liquid chromatography-quadrupole-time-of-flight mass spectrometry. J Chromatogr A. 2006;1124:68\u201381.","journal-title":"J Chromatogr A"},{"key":"9318_CR21","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1039\/C1AN15920H","volume":"137","author":"SK Byeon","year":"2012","unstructured":"Byeon SK, Lee JY, Moon MH. Optimized extraction of phospholipids and lysophospholipids for nanoflow liquid chromatography-electrospray ionization-tandem mass spectrometry. Analyst. 2012;137:451\u20138.","journal-title":"Analyst"},{"key":"9318_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.chroma.2012.03.073","volume":"1240","author":"DY Bang","year":"2012","unstructured":"Bang DY, Lim S, Moon MH. Effect of ionization modifiers on the simultaneous analysis of all classes of phospholipids by nanoflow liquid chromatography\/tandem mass spectrometry in negative ion mode. J Chromatogr A. 2012;1240:69\u201376.","journal-title":"J Chromatogr A"},{"key":"9318_CR23","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1002\/jms.3033","volume":"47","author":"S Lim","year":"2012","unstructured":"Lim S, Byeon SK, Lee JY, Moon MH. Computational approach to the structural identification of phospholipids using raw mass spectra from nanoflow liquid chromatography-electrospray ionization-tandem mass spectrometry. J Mass Spectrom. 2012;47:1004\u201314.","journal-title":"J Mass Spectrom"},{"key":"9318_CR24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.chroma.2015.01.004","volume":"1381","author":"SK Byeon","year":"2015","unstructured":"Byeon SK, Lee JY, Lee J-S, Moon MH. Lipidomic profiling of plasma and urine from patients with Gaucher disease during enzyme replacement therapy by nanoflow liquid chromatography-tandem mass spectrometry. J Chromatogr A. 2015;1381:132\u20139.","journal-title":"J Chromatogr A"},{"key":"9318_CR25","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1002\/rcm.520","volume":"15","author":"A Larson","year":"2001","unstructured":"Larson A, Uran S, Jacobsen PB, Skotland T. Collision-induced dissociation of glycerol phospholipids using electrospray ion-tran mass spectrometry. Rapid Commun Mass Sepctrom. 2001;15:2393\u20138.","journal-title":"Rapid Commun Mass Sepctrom"}],"container-title":["Analytical and Bioanalytical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-016-9318-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00216-016-9318-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00216-016-9318-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,4]],"date-time":"2022-06-04T01:12:58Z","timestamp":1654305178000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00216-016-9318-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,12]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["9318"],"URL":"https:\/\/doi.org\/10.1007\/s00216-016-9318-1","relation":{},"ISSN":["1618-2642","1618-2650"],"issn-type":[{"value":"1618-2642","type":"print"},{"value":"1618-2650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,12]]}}}